Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Microbiology Resource Announcements|September 24, 2024
Genome sequence of dengue virus serotype 1 isolated from a pediatric patient enrolled in an Ivermectin trial in ThailandPreeyanuch Sayboonruan, Adisak Songjaeng, Kwanrutai Chin-Inmanu, et al.Scientific Reports|December 13, 2022
Differential critical residues on the overlapped region of the non-structural protein-1 recognized by flavivirus and dengue virus cross-reactive monoclonal antibodiesPrasit Luangaram, Chamaiporn Tamdet, Chananya Saengwong, et al.ACS Infectious Diseases|June 29, 2024
An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing AntibodiesNapon Nilchan, Romchat Kraivong, Prasit Luangaram, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2016
Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin-Mediated NeutralizationSomchai Thiemmeca, Chamaiporn Tamdet, Nuntaya Punyadee, et al.Journal of Virology|November 21, 2014
Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infectionNuntaya Punyadee, Dumrong Mairiang, Somchai Thiemmeca, et al.Mbio|September 13, 2023
Dengue virus NS1 secretion is regulated via importin-subunit β1 controlling expression of the chaperone GRp78 and targeted by the clinical drug ivermectinSolène Denolly, Hongbo Guo, Miriam Martens, et al.Plos Neglected Tropical Diseases|November 20, 2020
Immortalized stem cell-derived hepatocyte-like cells: An alternative model for studying dengue pathogenesis and therapyKessiri Kongmanas, Nuntaya Punyadee, Kasima Wasuworawong, et al.Mbio|November 14, 2024
Whole-blood model reveals granulocytes as key sites of dengue virus propagation, expanding understanding of disease pathogenesisHansa Praneechit, Somchai Thiemmeca, Dararat Prayongkul, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 30, 2026
Dengue virus non-structural protein 1 as a surrogate biomarker of antiviral efficacy in early phase clinical trialsVaristha Metem, Dumrong Mairiang, Junjie Ding, et al.The Journal of Infectious Diseases|March 18, 2006
Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complementPanisadee Avirutnan, Nuntaya Punyadee, Sansanee Noisakran, et al.Pageof 3